Anaergia, Inc. · TSX:ANRG

Anaergia — Q3 2023 Earnings Presentation

10 slides from Anaergia's earnings presentation, Nov 14, 2023

  1. Slide 1: Anaergia Reports Third Quarter 2023 Financial Results - Investor Conference Call

    Anaergia Inc. Anaergia Reports Third Quarter 2023 Financial Results - Investor Conference Call Nov 14, 2023 TSX: ANRG Fueling a Sustainable World

  2. Slide 2: Disclaimers

    Disclaimers Forward-Looking Information Certain statements in this presentation and certain oral statements made by senior management during the earnings conference call on November 14, 2023 (collectively, this "presentation") are “forward-looking information” within the meaning of applicable Canadi

  3. Slide 3: Participating in Today's Call

    Participating in Today’s Call Brett Hodson Dr. Yaniv Scherson Andrew Spence Chief Executive Officer Chief Operating Officer Chief Financial Officer 3

  4. Slide 4: Summary

    Summary • Challenging times continue for the Company • Q3 Financials Statements and MD&A have been released • Strategic Review ongoing with some improvements in liquidity from recent transactions o Piper Sandler engaged in Q3 2023 to assist the Company o Sale of our six Italian Build-Own-Operate (“B

  5. Slide 5: Q3 Financial Overview

    Q3 Financial Overview 1. Key Disclosures • Substantial doubt about the Company’s ability to continue as a going concern • Closing of US$20 million financing for Rhode Island Bioenergy Facility • Agreement on the sale of the AIP financed portfolio in Italy 2. Key provisions and charges • Impairment o

  6. Slide 6: Q3 Financial Results

    Q3 Financial Results • Q3 2023 Revenue was lower by 24% compared to Q3 2022 primarily due to capital sale projects coming nearing completion and delay in new project bookings (CAD millions) Q3 2023 Q3 2022 YTD YTD 2023 2022 • Gross Margin for Q3 2023 was back to ~22% recovering from cost overruns an

  7. Slide 7: Update on BOO Assets

    Update on BOO Assets RBF Anaergia Bioenergy Facilities • The California state continues to implement and • SoCal Biomethane continues to ramp up towards enforce feedstock regulations as RBF undergoes capacity and is operating smoothly. restructuring under Chapter 11. • Construction on the Rhode Isla

  8. Slide 8: Strategic Review Ongoing

    Strategic Review Ongoing • As previously disclosed, the Company is continuing a business reset and is taking action to reduce the capital burden from future projects, improve margin, reduce SG&A, and conserve cash. • A Strategic Review was launched in Q3 2023 and is ongoing. Piper Sandler & Co. was

  9. Slide 9: Q&A

    Q&A 9

  10. Slide 10: Thank you for attending

    Thank you for attending 10

Anaergia — Q3 2023 Earnings Presentation on 6ix